Abstract
Patients with venous thromboembolism (VTE) associated with temporary risk factors are recommended to receive 3 months of oral anticoagulation therapy. However, most research on the optimal duration of anticoagulation therapy for VTE has focused on patients with deep-vein thrombosis. To determine the optimal duration after pulmonary embolism (PE), researchers in Italy randomized patients who had received 3 months of oral anticoagulation …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
